The choice of method for surfacing AI-relevant publications impacts the ultimate research findings. This report provides a quantitative analysis of various methods available to researchers for identifying AI-relevant research within CSET’s merged corpus, and showcases the research implications of each method.

Data Snapshots are informative descriptions and quick analyses that dig into CSET’s unique data resources. This short series explores how government procurement data can shed light on federal technological interest and utilization. It analyzes contract metadata, provided in a collaborative project with Govini, to track key emerging technologies through the federal procurement process.

Data Snapshots are informative descriptions and quick analyses that dig into CSET’s unique data resources. This five-part series uses data from the U.S. Department of Education and other select sources to complement existing CSET work on the U.S. AI workforce.

Vaccines keep the U.S. public healthy while safeguarding economic stability and biosecurity. This report assesses the domestic vaccine manufacturing landscape and identifies two major vulnerabilities: a reliance on foreign manufacturers and a lack of manufacturing redundancy. Maintaining a resilient vaccine supply will require the U.S. government to take steps to protect the existing supply, identify and monitor manufacturing vulnerabilities, and create a stronger domestic production base.

Pandemic threats are increasing as globalization, urbanization, and encroachment on animal habitats cause infectious outbreaks to become more frequent and severe. It is imperative that the United States build a pipeline of medical countermeasure development, beginning with basic scientific research and culminating in approved therapies. This report assesses preparedness for families of viral pathogens of pandemic potential and offers recommendations for steps the U.S. government can take to prepare for future pandemics.

U.S. policymakers are increasingly concerned about the national security implications of U.S. investments in China, and some are considering a new regime for reviewing outbound investment security. The authors identify the main U.S. investors active in the Chinese artificial intelligence market and the set of AI companies in China that have benefitted from U.S. capital. They also recommend next steps for U.S. policymakers to better address the concerns over capital flowing into the Chinese AI ecosystem.

CSET Non-Resident Senior Fellow Kevin Wolf testified before the Senate Banking Committee on U.S. export control policy and opportunities.

CSET's Dr. Caroline Schuerger, Dr. Steph Batalis, and Vikram Venkatram submitted this comment with recommendations for the National Biotechnology and Biomanufacturing Initiative.

CSET Non-Resident Senior Fellow Kevin Wolf testified before the House Foreign Affairs Oversight and Accountability Subcommittee regarding U.S. export control policy and his recommendations going forward.

CSET Non-Resident Senior Fellow Kevin Wolf testified before the United Kingdom Parliament on export controls and Russia.